Evidence map›Paper›PMID 32664734›Full record

ArticleJournal of the American Chemical Society2020

A Bioorthogonal Small Molecule Selective Polymeric "Clickase".

Junfeng Chen, Ke Li, Sarah E Bonson, Steven C Zimmerman

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Polymeric Micellar Nanocatalysts for CuAAC Click Reaction in Water.Langmuir : the ACS journal of surfaces and colloids · 2025
    Article
  3. Article
  4. Modular Fabrication of Bioorthogonal Nanozymes for Biomedical Applications.Advanced materials (Deerfield Beach, Fla.) · 2024
    Review
  5. Glutathione Mediates Control of Dual Differential Bio-orthogonal Labelling of Biomolecules.Angewandte Chemie (Weinheim an der Bergstrasse, Germany) · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Bioorthogonal nanozymes for breast cancer imaging and therapy.Journal of controlled release : official journal of the Controlled Release Society · 2023
    Article
  10. Chemical science · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Junfeng ChenDepartment of Chemistry, University of Illinois, Urbana, Illinois 61801, United States.ORCID 0000-0002-7100-0839
Ke LiDepartment of Chemistry, University of Illinois, Urbana, Illinois 61801, United States.ORCID 0000-0003-3851-7710
Sarah E BonsonDepartment of Chemistry, University of Illinois, Urbana, Illinois 61801, United States.ORCID 0000-0003-4167-3730
Steven C ZimmermanDepartment of Chemistry, University of Illinois, Urbana, Illinois 61801, United States.ORCID 0000-0002-5333-3437

Funding

Small Molecule Approaches to Targeting the DNA and RNA in Myotonic DystrophyR01AR069645 · NIAMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI ZIMMERMAN, STEVEN C. · 2017 to 2021
$2.2M
NIAMS NIH HHS R01 AR069645
6 · The paper itself

Abstract

Synthetic polymer scaffolds may serve as gatekeepers preventing the adhesion of biomacromolecules. Herein, we use gating to develop a copper-containing single-chain nanoparticle (SCNP) catalyst as an artificial "clickase" that operates selectively on small molecules that are able to penetrate the polymeric shell. Whereas the analogous clickase with surface ammonium groups performs highly efficient copper(I)-catalyzed alkyne-azide cycloaddition (CuAAC) reactions on both alkynylated proteins and small molecule substrates, the new SCNP clickase with polyethylene glycol (PEG) groups is only active on small molecules. Further, the new SCNP resists uptake by cells allowing extracellular click chemistry to be performed. We describe two proof of principle applications that illustrate the utility of the bioorthogonal activity. First, the SCNP catalyst is able to screen for ligands that bind proteins, including proteolysis targeting chimera (PROTAC)-like molecules. Second, the nonmembrane permeable SCNP can efficiently catalyze the click reaction extracellularly, thereby enabling in situ anticancer drug synthesis and screening without the catalyst perturbing intracellular functions.

Indexed as

Carbonic Anhydrase IICatalysisClick ChemistryCopperHeLa CellsHumansLigandsMetal NanoparticlesModels, MolecularMolecular StructurePolymersSmall Molecule LibrariesCarbonic Anhydrase IICopperLigandsPolymersSmall Molecule Libraries

Identifiers

PMID32664734
PMCPMC11214670

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.